GCI Virtual Summit Thought Leader – Dr. Anne Schlag, Drug Science

GCI Summit - Anne Schlag - Drug Science - GCI Virtual Summit - Global Cannabis Intelligence

GCI Virtual Summit Thought Leader – Dr. Anne Schlag, Drug Science

Anne participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.

Check out her bio below:

Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science. She holds Honorary Fellowships at both Imperial College London and King’s College London.

Within her role at Drug Science, she leads the research for the Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis.

Dr Anne Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.

If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.

You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.